Furosemid

Furosemide Struktur
54-31-9
CAS-Nr.
54-31-9
Bezeichnung:
Furosemid
Englisch Name:
Furosemide
Synonyma:
FRUSEMIDE;FUROSEMID;fursemide;Furosemide Injection;lasix;salix;4-CHLORO-N-FURFURYL-5-SULFAMOYLANTHRANILIC ACID;4-chloro-2-((furan-2-ylMethyl)aMino)-5-sulfaMoylbenzoic acid;ERIS;Furix
CBNumber:
CB2445739
Summenformel:
C12H11ClN2O5S
Molgewicht:
330.74
MOL-Datei:
54-31-9.mol

Furosemid Eigenschaften

Schmelzpunkt:
220 °C (dec.) (lit.)
Siedepunkt:
582.1±60.0 °C(Predicted)
Dichte
1.606
Brechungsindex
1.6580 (estimate)
Flammpunkt:
11 °C
storage temp. 
2-8°C
Löslichkeit
Practically insoluble in water, soluble in acetone, sparingly soluble in ethanol (96 per cent), practically insoluble in methylene chloride. It dissolves in dilute solutions of alkali hydroxides.
pka
pKa 3.8 (Uncertain)
Aggregatzustand
powder
Farbe
White to Off-White
Wasserlöslichkeit
Soluble in acetone, DMF or methanol. Slightly soluble in water
Merck 
14,4309
BCS Class
2 (CLogP), 4 (LogP)
Stabilität:
Stable, but light sensitive, air sensitive and hygroscopic. Incompatible with strong oxidizing agents.
InChIKey
ZZUFCTLCJUWOSV-UHFFFAOYSA-N
CAS Datenbank
54-31-9(CAS DataBase Reference)
IARC
3 (Vol. 50) 1990
EPA chemische Informationen
Furosemide (54-31-9)
Sicherheit
  • Risiko- und Sicherheitserklärung
  • Gefahreninformationscode (GHS)
Kennzeichnung gefährlicher T,F,Xi
R-Sätze: 61-39/23/24/25-23/24/25-11-36/37/38
S-Sätze: 7-16-36/37-45-53-36/37/39-22-36-26
RIDADR  UN 1230 3/PG 2
WGK Germany  3
RTECS-Nr. CB2625000
HS Code  2935904000
Giftige Stoffe Daten 54-31-9(Hazardous Substances Data)
Toxizität LD50 orally in female, male rats: 2600, 2820 mg/kg (Goldenthal)
Bildanzeige (GHS) GHS hazard pictogramsGHS hazard pictograms
Alarmwort Achtung
Gefahrenhinweise
Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
H302 Gesundheitsschädlich bei Verschlucken. Akute Toxizität oral Kategorie 4 Warnung GHS hazard pictogramssrc="/GHS07.jpg" width="20" height="20" /> P264, P270, P301+P312, P330, P501
Sicherheit
P202 Vor Gebrauch alle Sicherheitshinweise lesen und verstehen.
P264 Nach Gebrauch gründlich waschen.
P264 Nach Gebrauch gründlich waschen.
P270 Bei Gebrauch nicht essen, trinken oder rauchen.
P280 Schutzhandschuhe/Schutzkleidung/Augenschutz tragen.
P301+P312 BEI VERSCHLUCKEN: Bei Unwohlsein GIFTINFORMATIONSZENTRUM/Arzt/... (geeignete Stelle für medizinische Notfallversorgung vom Hersteller/Lieferanten anzugeben) anrufen.
P308+P313 BEI Exposition oder falls betroffen: Ärztlichen Rat einholen/ärztliche Hilfe hinzuziehen.

Furosemid Chemische Eigenschaften,Einsatz,Produktion Methoden

R-Sätze Betriebsanweisung:

R61:Kann das Kind im Mutterleib schädigen.
R39/23/24/25:Giftig: ernste Gefahr irreversiblen Schadens durch Einatmen, Berührung mit der Haut und durch Verschlucken.
R23/24/25:Giftig beim Einatmen, Verschlucken und Berührung mit der Haut.
R11:Leichtentzündlich.
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.

S-Sätze Betriebsanweisung:

S7:Behälter dicht geschlossen halten.
S16:Von Zündquellen fernhalten - Nicht rauchen.
S36/37:Bei der Arbeit geeignete Schutzhandschuhe und Schutzkleidung tragen.
S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn möglich, dieses Etikett vorzeigen).
S53:Exposition vermeiden - vor Gebrauch besondere Anweisungen einholen.
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
S22:Staub nicht einatmen.
S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.

Beschreibung

Furosemide (Item No. 26298) is an analytical reference standard categorized as a diuretic. Formulations containing diuretics, including furosemide, have been misused in sports for weight reduction and as masking agents in humans and to prevent exercise-induced pulmonary hemorrhage in racehorses. This product is intended for use in analytical forensic applications. This product is also available as a general research tool .

Chemische Eigenschaften

white to light yellow crystal powde

Verwenden

Furosemide inhibits ion co-transport in the kidney. Furosemide is used as a diuretic.

Definition

A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration and anti-hypertensive agent.

Allgemeine Beschreibung

Odorless white to slightly yellow crystalline powder. A diuretic drug. Almost tasteless.

Air & Water Reaktionen

Light sensitive. Air sensitive. Slightly soluble in water.

Reaktivität anzeigen

Furosemide may undergo hydrolysis at sufficiently low pH. The pH of aqueous solutions should be maintained in the basic range to prevent hydrolysis. Alcohol has been shown to improve the stability of Furosemide. Incompatible with strong oxidizing agents .

Hazard

Poison; moderately toxic; teratogen; questionable carcinogen; mutagen.

Brandgefahr

Flash point data for Furosemide are not available; however, Furosemide is probably combustible.

Biologische Aktivität

Loop diuretic that inhibits the Na + /2Cl - /K + (NKCC) cotransporter. Also acts as a non-competitive antagonist at GABA A receptors with ~ 100-fold greater selectivity for α 6-containing receptors than α 1-containing receptors.

Mechanism of action

Furosemide is a highly effective and quick-acting diuretic whose action, like all of the examined loop diuretics, is associated with blocking reabsorption of ions in the ascending bend of Henle’s loop. It is used for edema syndrome of various origins, edema of the lungs and brain, chronic renal insufficiency, some forms of hypertonic crises, and poisoning by barbiturates and other compounds excreted mainly with urine.

Clinical Use

Furosemide has a saluretic effect 8- to 10-fold that of the thiazide diuretics; however, it has a shorter duration of action (~6–8 hours). Furosemide causes a marked excretion of sodium, chloride, potassium, calcium, magnesium, and bicarbonate ions, with as much as 25% of the filtered load of sodium excreted in response to initial treatment. It is effective for the treatment of edemas connected with cardiac, hepatic, and renal sites. Because it lowers the blood pressure similar to the thiazide derivatives, one of its uses is in the treatment of hypertension.

Nebenwirkungen

Clinical toxicity of furosemide and other loop diuretics primarily involves abnormalities of fluid and electrolyte balance. As with the thiazide diuretics, hypokalemia is an important adverse effect that can be prevented or treated with potassium supplements or coadministration of potassium-sparing diuretics. Increased calcium ion excretion can be a problem for postmenopausal osteopenic women, and furosemide generally should not be used in these individuals. Hyperuricemia, glucose intolerance, increased serum lipid levels, ototoxicity, and gastrointestinal side effects might be observed as well. Hypersensitivity reactions also are possible with furosemide (a sulfonamide-based drug), and cross-reactivity with other sulfonamide containing drugs is possible.

Sicherheitsprofil

Poison by intravenous route. Moderately toxic by ingestion and intraperitoneal routes. Human systemic effects by intravenous route: change in the sensitivity of the ear to sound, tinnitus, unspecified effects on the heart, constriction of the arteries, a decrease in urine volume, interstitial nephritis, metabolic alkalosis, pulse rate decrease, fall in blood pressure. Ingestion can damage the liver. Experimental teratogenic and reproductive effects. Questionable carcinogen with experimental carcinogenic effects. Human mutation data reported. When heated to decomposition it emits very toxic fumes of Cl-, NOx, and SOx.

Furosemid Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Furosemid Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 635)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Hebei Mojin Biotechnology Co., Ltd
+8613288715578
sales@hbmojin.com China 12471 58
Hebei Yanxi Chemical Co., Ltd.
+8617531190177
peter@yan-xi.com China 6000 58
Shandong Huisheng Import & Export Co., Ltd.
+86-13176845580 +86-13176845580
da@zhongda-biotech.com China 248 58
Anhui Zhongda Biotechnology Co., Ltd
+8619956560829
justine@zhongda-biotech.com China 300 58
Anhui Zhongda Biotechnology Co., Ltd
+8615689548120
linda@zhongda-biotech.com China 204 58
Anhui Ruihan Technology Co., Ltd
+8617756083858
daisy@anhuiruihan.com China 994 58
Liaoning Pharmaceutical Innovation Co., Ltd
+8616588669988
sales@pipharma.com.cn China 150 58
Sigma Audley
+86-18336680971 +86-18126314766
nova@sh-teruiop.com China 525 58
Shaanxi TNJONE Pharmaceutical Co., Ltd
+8618740459177
sarah@tnjone.com China 1094 58
Ouhuang Engineering Materials (Hubei) Co., Ltd
+8617702722807
admin@hbouhuang.com China 3001 58

54-31-9(Furosemid)Verwandte Suche:


  • 5-(AMINOSULPHONYL)-4-CHLORO-2-[(2-FURANYLMETHYL)AMINO]BENZOIC ACID
  • 5-[AMINOSULFONYL]-4-CHLORO-2-[(2-FURANYLMETHYL)AMINO]BENZOIC ACID
  • LABOTEST-BB LT00244801
  • FUROSEMIDE
  • 2-furfurylamino-4-chloro-5-sulfamoylbenzoic acid
  • FUROSEMIDE METHANOL SOLUTION
  • FUROSEMIDE, RELATED COMPOUND B 4-CHLORO-5-SULFAMOYLANTHRANILIC ACID USP STANDARD
  • FUROSEMIDE, EP STANDARD
  • FUROSEMIDE, IMP. A (EP):2-CHLORO-4-FURFURYLAMINO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD)
  • FUROSEMIDE, IMP. B (EP): 2,4-DICHLORO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD)
  • FUROSEMIDE, MM(CRM STANDARD)
  • FUROSEMIDE, WHO(CRM STANDARD)
  • FUROSEMIDE, IMP. C (EP): 2-AMINO-4-CHLORO-5-SULPHAMOYLBENZOIC ACID MM(CRM STANDARD)
  • FUROSEMIDE, IMPURITY A2-CHLORO-4-(FURFURYLAMINO)-5-SULPHAMOYLBENZOIC ACID EP STANDARD
  • FUROSEMIDE, USP STANDARD
  • FUROSEMIDE, BP STANDARD(CRM STANDARD)
  • FUROSEMIDE, RELATED COMPOUND A 2-CHLORO-4-N-FURFURYLAMINO-5-SULFAMOYLBENZOIC ACID USP STANDARD
  • FUROSEMIDE UNLABELED 1.0 MG/ML IN METHANOL
  • Furosemide for peak identification
  • ANTI-TM173(C-TERMINAL) antibody produced in rabbit
  • ERIS
  • TMEM173
  • Transmembrane protein 173
  • Furosemide (furosemide)
  • Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-(2-furanylmethyl)amino-
  • FUROSEMIDE,1.0MG/MLINMETHANOL
  • FUROSEMIDE,USP
  • 4-chloro-2-(2-furylmethylamino)-5-sulfamoyl-benzoic acid
  • 4-CHLORO-N-(2-FURYLMETHYL)-5-SULPHAMOYLANTHRANILICACID
  • FUROSEMIDE (FRUSEMIDE)
  • 5-(Aminosulfonyl)-4-chloro-2-[(2-pyranylmethyl)-amino]benzonium acid
  • 4-Chloro-N-furfuryl-5-sulfamoylanthranilic acid, 5-(Aminosulfonyl)-4-chloro-2-([2-furanylmethyl]amino)benzoic acid
  • Furosemide solution
  • Furix
  • Furomex
  • Lazax
  • N-(2-furylmethyl)-4-chloro-5-sulfamylanthranilic acid
  • "mita"
  • 4-chloro-n-(2-furylmethyl)-5-sulfanoylanthranilicacid
  • 4-chloro-n-furfuryl-5-sulfamoyl-anthranilicaci
  • 5-(aminosulfonyl)-4-chloro-2-((2-furanylmethyl)amino)-benzoicaci
  • 5-(aminosulfonyl)-4-chloro-2-[(2-furanylmethyl)amino]-benzoicaci
  • 5-(Aminosulfonyl)-4-chloro-2-[2-(furamyl-methyl)amino]-benzoicacid
  • aluzine
  • aquasin
  • arasemide
  • chlor-n-(2-furylmethyl)-5-sulfamylanthranilsaeure
  • diurolasa
  • endural
  • franyl
  • frusemin
  • furanthril
  • furanthryl
  • furantril
  • furose
  • furosemide"mita"
  • furosemidu
  • furoside
Copyright 2019 © ChemicalBook. All rights reserved